Table 2.
Variables | Total Patients (n = 386) |
---|---|
Sex (m/f) | 309/77 |
Age (years) | 62.4 ± 13.14 |
Etiology, n (%) | |
Alcohol | 273 (70.7) |
Hepatitis B virus | 17 (4.4) |
Hepatitis C virus | 18 (4.7) |
Autoimmune disease | 26 (6.7) |
Wilson disease | 3 (0.8) |
Toxic | 3 (0.8) |
Cryptogenic | 52 (13.5) |
Laboratory test | |
Hb (g/L) a | 111.10 ± 81.62 |
WBC (109/L) a | 9.35 ± 5.23 |
PLT (109/L) a | 129.887 ± 85.65 |
TBIL (mmol/L) b | 81 (100) |
Alb (g/L) b | 27 (5) |
AST (U/L) b | 82 (97) |
ALT (U/L) b | 31 (27) |
ALP (U/L) b | 156 (213) |
GGT (U/L) b | 68 (1590) |
BUN (mmol/ L) b | 13.2 (25) |
Cr (µmol/L) b | 115 (268) |
INR b | 1.7 (1.78) |
D-dimer (mg/L) b | 6.18 (28.1) |
CRP (mg/L) b | 43.5 (127) |
Pct (ng/L) b | 3.0 (12.7) |
Na (mmol/L) b | 136.20 ± 6.14 |
K (mmol/L) b | 4.28 ± 0.92 |
LDH (U/L) b | 675 (1168) |
NH4 (µmol/L) b | 89 (59) |
Cholesterol (mmol/L) | 3.30 ± 1.97 |
Triglycerides (mmol/L) | 1.27 ± 0.82 |
MELD score b | 16.4 (13.5) |
APRI score b | 1.48 (2.64) |
AAR score b | 1.9 (1.12) |
FIB-4 score b | 6.15 (7.66) |
King score b | 1036 (1841.28) |
FI score b | 4.1 (1.33) |
Loc score b | 4.08 (3.97) |
ALBI score b | −1.11 (0.89) |
PALBI score b | −1.54 (0.66) |
ABIC score b | 8.43 (2.15) |
Abbreviations: a mean ± SD, b median(IQR), pts—patients, n—number of patients, Hb—hemoglobin, WBC—white blood cell, Plt—platelet, TBil—total bilirubin, Alb—albumin, AST—aspartate aminotransferase, ALT—alanine aminotransferase, ALP—alkaline phosphatase, GGT—gamma glutamyltransferase, BUN—blood urea nitrogen, Cr—creatinine, INR—international normalized ratio, CRP—C-reactive protein, Pct—procalcitonin, Na—sodium, K—potassium, LDH—lactic acid dehydrogenase, NH4—ammonium ion, MELD—model for end-stage liver disease, APRI—AST to platelet ratio index, AAR—aspartate aminotransferase-to-alanine aminotransferase ratio, FIB—fibrosis-4 index, FI—fibrosis index, ALBI—albumin-bilirubin, PALBI—platelet-albumin-bilirubin, ABIC—Age, bilirubin, INR, creatinine score.